Target intelligence / Profile preview

GGCT pseudogene 1 (GGCTP1)

Target: GGCTP1
Molecular classification: Other (pseudogene)

Overview

GGCT pseudogene 1 (GGCTP1) is a processed pseudogene related to the Gamma-glutamylcyclotransferase (GGCT) gene. It shares high sequence similarity with the GGCT gene but contains nucleotide changes, insertions, and deletions that disrupt its coding potential, meaning it cannot produce a functional protein[1]. Pseudogenes like GGCTP1 may have regulatory roles at the RNA level, such as acting as competitive endogenous RNAs (ceRNAs), but there is no evidence for GGCTP1 being directly involved in disease, drug interactions, or clinical diagnostics. Its presence is an artifact of genome evolution and is not considered a canonical biological target for therapy or drug development[1][2][4].

Other names: GGCTP1Gamma-glutamylcyclotransferase pseudogene 1

Biological functions

Potential competitive endogenous RNA (ceRNA) activity (inferred from general pseudogene function, not GGCTP1-specific)No known enzyme or receptor function; not involved in canonical glutathione metabolism

Disease associations

Possible involvement as a biomarker in certain disease contexts (based on pseudogene literature, but no specific data for GGCTP1)No direct role in diseases like cancer, inflammation, etc., that has been established for GGCTP1 itself

Beyond the preview

Go deeper on GGCT pseudogene 1 (GGCTP1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on GGCT pseudogene 1 (GGCTP1).

Explore the full profile